The HSE's financial statements for 2025 record total expenditure of €30.4 billion. This was up 7% from the €28.3 billion spent in 2024. A total of €25.5 billion of the HSE’s funding for 2025 was from the health Vote. Funding for specialist disability services totalling €3.5 billion was provided to the HSE by the Vote for children, disability and equality. Over €100 million was received from other State agencies, including the National Treatment Purchase Fund, NTPF. The HSE was allowed to retain receipts from employee pension contributions and other payroll deductions totalling €504 million. Income from patient charges amounted to just under €310 million. Non-capital expenditure in 2025 exceeded income by just over €1 billion and this deficit was carried forward to be met as a first charge from the funding provided from the health Vote in 2026. On the capital side, there was a deficit of €19.7 million in 2025.
I issued a clear audit opinion in relation to the financial statements. However, in my report I drew attention to a number of matters which I will now briefly outline. The HSE incurred charges of €8.4 million in respect of Covid-19 vaccines held at the year's end which had reached their expiry dates or were determined no longer to be clinically suitable for use. The equivalent write-off was €11.1 million in 2024.
In 2025, the HSE also incurred storage costs amounting to €1.5 million in respect of stocks of legacy and obsolete personal protective equipment, PPE. The cumulative cost of storing the obsolete items to the end of 2025 was €8.85 million. A further €6.7 million was incurred by the executive in 2025 to dispose of this obsolete stock in an environmentally secure manner using a specialist service provider.
The executive acknowledges in the statement on internal control that delays occurred in submitting some completed forms to a private insurer in 2025 and discloses that around €3.4 million in patient income was lost in 2025 as a result. The loss for similar reasons in 2024 was estimated at €4.1 million.
As in previous years, my audit report for 2025 drew attention to non-compliant procurement, which remains a significant issue for the HSE. The HSE reviewed the compliance status of €1.8 billion, or 33%, of its spend on procurement of goods and services. The sample reviewed was based on invoices individually over €25,000 each. From this subset of invoices, HSE managers reported that 5% of the value of the sample invoices, or €90 million, had been procured in a manner that was non-compliant. In itself, this is a significant non-compliant procurement level.
Additionally, in 2025 the executive carried out an exercise on a sample of procurements below €25,000 each. Expenditure to the value of €6.3 million was reviewed. This exercise identified that the procurement non-compliance rate in respect of the sample transactions examined was 16%. The overall rate of procurement non-compliance is not known, because the spending within the scope of the review may not be representative of the executive’s overall procurement of goods and services. However, the system-wide operation of the HSE's integrated financial management system may allow for better, more representative sampling of spending for review, and for more reliable estimates to be reported in the future.
The analysis of HSE personnel remuneration by pay band indicates that 11 employees, all of whom are medical consultants, were paid in excess of €500,000 each in 2025. The top ten earners received a combined €6.8 million in 2025. Four of the top earners were employed in one of the HSE’s acute hospitals. The highest earner received almost €910,000 in total remuneration in 2025, of which over €616,000 was recorded as payments for additional work, including overtime, fees and session payments. Payments totalling €324,000 related to additional work carried out by the employee in 2023 and 2024. The remaining €586,000 related to work carried out in 2025, but the audit noted that the employee had submitted claims and been paid in respect of additional work only up to May 2025, so significant additional outlay may arise in respect of that year.
In 2025, the HSE provided non-capital grant funding of €8.4 billion to outside agencies. Agencies that received €100,000 or more are listed individually in appendix 1 of the financial statements, showing the amount of funding provided. Annual grant funding of the agencies should be covered by the relevant form of funding and service contract or agreement. The level of detail in the standard agreements varies depending on the grant level. To be effective as a control over the level and timing of grant funding and the related level of service to be delivered, the relevant funding agreement should be in place early in the funding year. The audit found that by the end of March 2025, only 4% of grant funding issued in 2025 was covered by a funding agreement. More agreements were signed as the year progressed, but the statement on internal control indicates that, even by the end of the year, 11% of the funding for 2025 was still not covered by a completed funding agreement.
I also noted that the statement on internal control discloses weaknesses around the control and management of fixed assets in the HSE. These include inconsistencies in the application of HSE financial regulations, instances where assets no longer in use remained on asset registers, and capital projects where some costs were not included on asset registers.
I have raised concerns previously about these shortcomings related to fixed assets. In 2024, the HSE committed to establishment of a working group to address the issues. However, we noted that the working group’s first meeting took place only in March 2026.
I noted in my report that the statement on internal control discloses that the Data Protection Commission had conducted a review of two data breaches arising from failures in the HSE's handling of patient records and that fines were expected to arise from these failures. Subsequently, the commission issued its report and recommendations and imposed fines on the HSE to the overall total of €945,000 in respect of both breaches.